These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21722587)

  • 1. Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate.
    Boyd A; Casselini C; Vinik E; Vinik A
    J Diabetes Sci Technol; 2011 May; 5(3):714-22. PubMed ID: 21722587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
    Casellini CM; Barlow PM; Rice AL; Casey M; Simmons K; Pittenger G; Bastyr EJ; Wolka AM; Vinik AI
    Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy.
    Vinik EJ; Hayes RP; Oglesby A; Bastyr E; Barlow P; Ford-Molvik SL; Vinik AI
    Diabetes Technol Ther; 2005 Jun; 7(3):497-508. PubMed ID: 15929681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
    Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
    J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Monochromatic Infrared Energy on Quality of Life and Intraepidermal Nerve Fiber Density in Painful Diabetic Neuropathy: A Randomized, Sham Control Study.
    Rastogi A; Uppula P; Saikia U; Bhansali A
    Neurol India; 2021; 69(5):1331-1337. PubMed ID: 34747807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical measures in transthyretin familial amyloid polyneuropathy.
    Coelho T; Vinik A; Vinik EJ; Tripp T; Packman J; Grogan DR
    Muscle Nerve; 2017 Mar; 55(3):323-332. PubMed ID: 27422379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. German-translated Norfolk quality of life (QOL-DN) identifies the same factors as the English version of the tool and discriminates different levels of neuropathy severity.
    Vinik EJ; Paulson JF; Ford-Molvik SL; Vinik AI
    J Diabetes Sci Technol; 2008 Nov; 2(6):1075-86. PubMed ID: 19885296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.
    Tesfaye S; Tandan R; Bastyr EJ; Kles KA; Skljarevski V; Price KL;
    Diabetes Care; 2007 Oct; 30(10):2626-32. PubMed ID: 17623822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy.
    Vinik EJ; Vinik AI; Paulson JF; Merkies IS; Packman J; Grogan DR; Coelho T
    J Peripher Nerv Syst; 2014 Jun; 19(2):104-14. PubMed ID: 24738700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.
    Bastyr EJ; Price KL; Bril V;
    Clin Ther; 2005 Aug; 27(8):1278-94. PubMed ID: 16199253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Screening Tools for the Early Detection of Peripheral Neuropathy in Adults with and without Type 2 Diabetes.
    Brown JJ; Pribesh SL; Baskette KG; Vinik AI; Colberg SR
    J Diabetes Res; 2017; 2017():1467213. PubMed ID: 29250555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Three Months of Honey Supplementation on Quality of Life and Neuropathy in Type 2 Diabetic Patients.
    Sirisha A; Singh Gaur G; Pal P; Suryanarayana BS; Bobby Z; Pal GK
    Altern Ther Health Med; 2021 Jun; 27(S1):54-60. PubMed ID: 33789248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the quality of life over a 4-year period of time in Romanian patients with diabetes mellitus.
    Vonica CL; Gâvan NA; Cosma DT; Sima DI; Vinik EJ; Vinik A; Veresiu AI; Bondor CI
    Int J Clin Pract; 2021 Jun; 75(6):e14076. PubMed ID: 33550660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial.
    Didangelos T; Karlafti E; Kotzakioulafi E; Margariti E; Giannoulaki P; Batanis G; Tesfaye S; Kantartzis K
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33513879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of axonal ion channel dysfunction on quality of life in type 2 diabetes.
    Kwai NC; Arnold R; Wickremaarachchi C; Lin CS; Poynten AM; Kiernan MC; Krishnan AV
    Diabetes Care; 2013 May; 36(5):1272-7. PubMed ID: 23404298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of a novel sub-item mortality risk score derived from the Norfolk Quality of Life in Diabetic Neuropathy questionnaire in Romanian participants with diabetes mellitus.
    Bondor CI; Cosma DT; Florea B; Sima DI; Tăuţ A; Vereşiu IA; Vinik EJ; Vinik A; Vonica C; Gâvan NA
    Prim Care Diabetes; 2022 Oct; 16(5):684-691. PubMed ID: 35915012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-specific quality of life in patients with diabetic neuropathy.
    Alghamdi M; Owolabi LF; Adamu B; Taura MG; Jibo A; Almansour M; Alaklabi SN; Alghamdi MA; Imam IA; Abdelrazak R; Rafaat A; Aliyu MH
    Saudi Med J; 2022 Apr; 43(4):408-417. PubMed ID: 35414620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of small nerve fiber dysfunction in type 2 diabetes.
    Ekman L; Thrainsdottir S; Englund E; Thomsen N; Rosén I; Hazer Rosberg DB; Petersson J; Eriksson KF; Dahlin LB
    Acta Neurol Scand; 2020 Jan; 141(1):38-46. PubMed ID: 31549387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction.
    Casellini CM; Parson HK; Richardson MS; Nevoret ML; Vinik AI
    Diabetes Technol Ther; 2013 Nov; 15(11):948-53. PubMed ID: 23889506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.